Liberia Health Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials

International Study on COVID-19 Vaccine to Assess Immunogenicity, Reactogenicity and Efficacy (InVITE)
Condition:   COVID-19 Intervention:   Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo;   Partnership for Clinical Research in Guinea/Partenariat de Recherche Clinique en Guinée (PREGUI);   National Institute of Health Resea rch and Development, Ministry of Health Republic of Indonesia;   Partnership for Research on Ebola Virus in Liberia (PREVAIL);   University Clinical Research Center, Mali;   National Institute of Medical Sciences and Nutrition, Salvador Zubiran Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2021 Category: Research Source Type: clinical trials